Related references
Note: Only part of the references are listed.The human connectome in Alzheimer disease - relationship to biomarkers and genetics
Meichen Yu et al.
NATURE REVIEWS NEUROLOGY (2021)
FDG-PET patterns associated with ideomotor apraxia and imitation apraxia in patients with corticobasal syndrome
Sungyang Jo et al.
PARKINSONISM & RELATED DISORDERS (2021)
Metabolic and Structural Signatures of Speech and Language Impairment in Corticobasal Syndrome: A Multimodal PET/MRI Study
Jacy Bezerra Parmera et al.
FRONTIERS IN NEUROLOGY (2021)
Visual versus semiquantitative analysis of F-18 fluorodeoxyglucose-positron emission tomography brain images in patients with dementia
Ismet Sarikaya et al.
WORLD JOURNAL OF NUCLEAR MEDICINE (2021)
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
Gael Chetelat et al.
LANCET NEUROLOGY (2020)
Spatial Patterns of Hypometabolism and Amyloid Deposition in Variants of Alzheimer's Disease Corresponding to Brain Networks: a Prospective Cohort Study
Ying Wang et al.
MOLECULAR IMAGING AND BIOLOGY (2019)
Clinical and neuroimaging characteristics of clinically unclassifiable primary progressive aphasia
Rene L. Utianski et al.
BRAIN AND LANGUAGE (2019)
The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy
Alessandra Dodich et al.
NEUROIMAGE-CLINICAL (2019)
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain F-18-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus
F. Nobili et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia
Femke Bouwman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Structural, Microstructural, and Metabolic Alterations in Primary Progressive Aphasia Variants
Alexandre Routier et al.
FRONTIERS IN NEUROLOGY (2018)
The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia
Chiara Cerami et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease
Julian Dronse et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
Valentina Garibotto et al.
NEUROBIOLOGY OF AGING (2017)
Consensus classification of posterior cortical atrophy
Sebastian J. Crutch et al.
ALZHEIMERS & DEMENTIA (2017)
The impact of different 18FDG PET healthy subject scans for comparison with single patient in SPM analysis
Francesca Gallivanone et al.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Spatial Patterns of Atrophy, Hypometabolism, and Amyloid Deposition in Alzheimer's Disease Correspond to Dissociable Functional Brain Networks
Michel J. Grothe et al.
HUMAN BRAIN MAPPING (2016)
Differential patterns of regional cerebral hypometabolism according to the level of cerebral amyloid deposition in patients with amnestic mild cognitive impairment
So Yeon Jeon et al.
NEUROSCIENCE LETTERS (2016)
Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes
Jordi A. Matias-Guiu et al.
JOURNAL OF NEUROLOGY (2015)
18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias
Carl Taswelll et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography
Sharon J. Sha et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia
Chiara Cerami et al.
NEUROIMAGE-CLINICAL (2015)
Visual Versus Semi-Quantitative Analysis of F-18-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project
Silvia Morbelli et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia
Pasquale Anthony Della Rosa et al.
NEUROINFORMATICS (2014)
Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting
Daniela Perani et al.
NEUROIMAGE-CLINICAL (2014)
Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease
Manja Lehmann et al.
BRAIN (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Clinical diagnostic criteria and classification controversies in frontotemporal lobar degeneration
Katya Rascovsky et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2013)
Diagnostic criteria for corticobasal syndrome: a comparative study
Robert Mathew et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Temporoparietal Hypometabolism in Frontotemporal Lobar Degeneration and Associated Imaging Diagnostic Errors
Kyle B. Womack et al.
ARCHIVES OF NEUROLOGY (2011)
Temporoparietal atrophy: A marker of AD pathology independent of clinical diagnosis
Jennifer L. Whitwell et al.
NEUROBIOLOGY OF AGING (2011)
The concept of FDG-PET endophenotype in Alzheimer's disease
Emmanuel H. During et al.
NEUROLOGICAL SCIENCES (2011)
Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution
M. H. Rosenbloom et al.
NEUROLOGY (2011)
Classification of primary progressive aphasia and its variants
M. L. Gorno-Tempini et al.
NEUROLOGY (2011)
Reduced Cortical Thickness in the Posterior Cingulate Gyrus is Characteristic of Both Typical and Atypical Alzheimer's Disease
Manja Lehmann et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
A beta Amyloid and Glucose Metabolism in Three Variants of Primary Progressive Aphasia
Gil D. Rabinovici et al.
ANNALS OF NEUROLOGY (2008)
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
Norman L. Foster et al.
BRAIN (2007)
What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
W. Jagust et al.
NEUROLOGY (2007)
Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
Anne M. Fagan et al.
ARCHIVES OF NEUROLOGY (2007)
Positron emission tomography in evaluation of dementia - Regional brain metabolism and long-term outcome
DHS Silverman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Neural and cognitive bases of upper limb apraxia in corticobasal degeneration
P Peigneux et al.
NEUROLOGY (2001)
Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation
S Minoshima et al.
ANNALS OF NEUROLOGY (2001)
Share Paper
